Trademark Overview
On Tuesday, January 18, 2011, a trademark application was filed for CIRACARD with the United States Patent and Trademark Office. The USPTO has given the CIRACARD trademark a serial number of 85219826. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, January 25, 2011. This trademark is owned by Forest Laboratories, Inc.. The CIRACARD trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine
